esketamine
Commercial- Indications
- Treatment-resistant depression
Company intelligence / Profile preview
Stella MSO operates more than 20 mental health clinics across the U.S. and Israel. The company specializes in interventional psychiatry for conditions such as PTSD, anxiety, and depression using advanced protocols like Stellate Ganglion Block and Deep TMS. It has treated over 30,000 patients to date and recently received a $5 million minority investment from BrainsWay to accelerate growth.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stella MSO.